Intracardiac mobile thrombus and D-dimer fragment of fibrin in patients with mitral stenosis

Br Heart J. 1991 Jul;66(1):22-5. doi: 10.1136/hrt.66.1.22.

Abstract

Objective: To investigate the relation between intracardiac thrombus and blood coagulability in patients with mitral stenosis.

Design: Prospective study. Cross sectional echocardiography and plasma concentrations of the D-dimer fragment of fibrin were used concurrently to detect intracardiac thrombus in patients with mitral stenosis.

Setting: Department of Medicine, National Cardiovascular Centre, Osaka, Japan.

Patients: 63 patients with mitral stenosis. None of them had been receiving any anticoagulants or antiplatelet agents.

Main outcome measures: Plasma concentrations of D-dimer in patients with a mobile intracardiac thrombus, those in patients with a non-mobile intracardiac thrombus, and those in patients without an intracardiac thrombus.

Results: A mobile intracardiac thrombus was found in 10 patients and a non-mobile thrombus in eight. The remaining 45 patients had no intracardiac thrombi. Plasma concentrations of D-dimer in the 10 patients with a mobile thrombus were all greater than 300 ng/ml (mean 983.3, 95% confidence interval 498.9 to 1467.7 ng/ml) and they were significantly higher than those in the patients with a non-mobile thrombus (226.2, 33.6 to 418.8 ng/ml) and the patients without an intracardiac thrombus (147.2, 110.4 to 184 ng/ml).

Conclusions: A high plasma concentration of D-dimer seemed to reflect a hypercoagulable intracardiac state and may be a helpful indicator of the possible presence of mobile intracardiac thrombus in patients with mitral stenosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifibrinolytic Agents / blood*
  • Echocardiography
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Heart Diseases / blood*
  • Heart Diseases / diagnostic imaging
  • Humans
  • Middle Aged
  • Mitral Valve Stenosis / blood*
  • Mitral Valve Stenosis / diagnostic imaging
  • Thrombosis / blood*
  • Thrombosis / diagnostic imaging

Substances

  • Antifibrinolytic Agents
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D